Investigation of oesophageal adenocarcinoma for viral genomic sequences

European Journal of Surgical Oncology

Volumn 23, Issue 1, 1997, Pages 24-29

  Morgan, Richard J ^a   Perry, Anthony C F ^b   Newcomb, Paul V ^a   Hardwick, Richard H ^a   Alderson, Derek ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Oesophageal neoplasms; Protein p53; Viruses

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADENOVIRUS 12; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; EPSTEIN BARR VIRUS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS GENOME; WART VIRUS;

EID: 0031038247     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)80138-2     Document Type: Article

References (34)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JJ. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
2. Powell J. McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62: 440-3.
3. Barrett. Chronic peptic ulcer of the oesophagus and oesophagitis. Br J Surg 1950; 38: 175-82.
4. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the Esophagogastric junction and Barrett's Esophagus. Gastroenterology 1995; 109: 1541-6.
5. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic esophagitis. Am J Gastroenterol 1990; 99: 918-22.
6. Fennerty MB, Sampliner RE, Garewal HS. Review article: Barrett's oesophagus - cancer risk, biology and therapeutic management. Aliment Pharmacol Ther 1993; 7: 339-45.
7. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991: 32: 1441-6.
8. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
9. Neshat K, Sanchez CA, Galipeau PC, et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994; 106: 1589-95.
10. Blount PL, Ramel S, Raskind WH, et al. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res 1991; 51: 5482-6.
11. Flejou JF, Potet F, Muzeau F, Le PF, Fekete F, Henin D. Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J Clin Pathol 1993; 46: 330-3.
12. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994; 35: 764-8.
13. Casson AG, Manolopoulos B, Troster M, et al. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am J Surg 1994; 167: 52-7.
14. Moore JH, Lesser EJ, Erdody DH, Natale RB, Orringer MB, Beer DG. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer 1994; 56: 487-93.
15. Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 1995; 108: 1176-82.
16. Dix B, Robbins P, Carrello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994; 70: 585-90.
17. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-6.
18. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
19. van den Heuvel SJ, van Laar T, The I, van der Eb AJ. Large El B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol 1993; 67: 5226-34.
20. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-4.
21. Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 1993; 90: 5455-9.
22. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, D.M. B. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992; 101: 183-9.
23. Van Noorden S. Tissue preparation and immunostaining techniques for light microscopy. In: Polak J, Van Noorden S (eds) Immunohistochemistry: Modern Methods and Applications (2nd edn). Wright, 1986: 26-53.
24. van den Brule AJ, Snijders PJ, Gordijn RL, Bleker OP, Meijer CJ, Walboomers JM. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990; 45: 644-9.
25. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992; 52: 5323-8.
26. Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-17.
27. Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994; 107: 128-36.
28. Chang F, Syrjanen S, Shen Q, Wang L, Syrjanen K. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993; 72: 2525-30.
29. Durst M, Gissmann L, Ikenberg H, zur HH. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812-5.
30. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur HH. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3: 1151-7.
31. Zur Hausen H, Schulte HH, Holthausen H. Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells. Nature 1970; 227: 245-8.
32. Mori M, Watanabe M, Tanaka S, Mimori K, Kuwano H, Sugimachi K. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med 1994; 118: 998-1001.
33. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80-3.
34. Esteve A, Lehman T, Jiang W, et al. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog 1993; 8: 306-11.